XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities    
Net income $ 4,243,623 $ 2,678,429
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 1,824,517 1,613,394
Change in allowance for doubtful accounts 0 210,000
Amortization of discount on investments (64,327) (43,601)
Stock-based compensation 541,884 1,535,628
Changes in operating assets and liabilities:    
Accounts receivable, net 18,912 3,308,314
Inventories, net (5,868,972) 625,873
Other assets 190,796 (116,872)
Accounts payable, accrued expenses and deferred rent 1,553,798 (901,754)
Net cash provided by operating activities 2,440,231 8,909,411
Cash flows from investing activities    
Purchases of property, plant and equipment and intangible assets (1,493,341) (1,099,089)
Purchases of investments (31,837,930) (17,444,393)
Proceeds from maturities of investments 30,163,000 7,235,000
Net cash used in investing activities (3,168,271) (11,308,482)
Cash flows from financing activities    
Proceeds from issuance of common stock under employee stock purchase plan 348,776 313,891
Proceeds from issuance of common stock upon exercise of stock options 10,968 24
Tax withholding related to vesting of restricted stock grants (5,803) (431,779)
Repurchase of common stock (428,654) 0
Net cash used in financing activities (74,713) (117,864)
Decrease in cash and cash equivalents (802,753) (2,516,935)
Cash and cash equivalents, beginning of period 10,081,721 8,547,777
Cash and cash equivalents, end of period 9,278,968 6,030,842
Supplemental disclosures for cash flow information    
Cash paid during the year for income taxes 469,529 1,081,068
Non-cash financing activities    
Cashless exercise of stock options $ 10,962 $ 17,390